iRhythm Technologies Inc.(IRTC)30日盘后大跌11.7%,报收于67.8美元。公司此前公布的2024财年第三季度财报数据令市场失望,成为导致股价重挫的主因。
财报显示,iRhythm第三季度每股亏损1.26美元,远超过分析师预期的每股亏损57美分。虽然公司营收同比增长18.4%至1.4754亿美元,但也未达到华尔街1.4673亿美元的预期水准。
作为一家先进医疗设备公司,iRhythm第三季度净亏损高达4618万美元。分析师认为,公司产品和服务需求强劲,但成本管控不利和运营效率较低,以至于利润表现远不及预期,导致股价大幅下跌。美股投资人对公司业绩前景产生担忧情绪。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.